Volume 132, Issue 3, Pages (March 2007)

Slides:



Advertisements
Similar presentations
Targeting Improves MSC Treatment of Inflammatory Bowel Disease
Advertisements

Volume 25, Issue 3, Pages (June 2006)
Feeding with olive oil attenuates inflammation in dextran sulfate sodium-induced colitis in rat  Toru Takashima, Yasuhisa Sakata, Ryuichi Iwakiri, Ryosuke.
Fig. 1. Treatment with S. japonicum cercariae resulted in reduced susceptibility to DSS-induced colitis in mice. Mice were infected with 20±2 S. japonicum.
Experimental Models of Inflammatory Bowel Diseases
Volume 131, Issue 4, Pages (October 2006)
Volume 17, Issue 5, Pages (November 2002)
Immunopathological characterization of selected mouse models of inflammatory bowel disease: Comparison to human disease  Yava L. Jones-Hall, Matthew B.
Volume 135, Issue 1, Pages (July 2008)
Volume 119, Issue 1, Pages (July 2000)
Volume 25, Issue 2, Pages (August 2006)
Volume 140, Issue 2, Pages e2 (February 2011)
Carcinogenesis of Helicobacter pylori
Long-Term Budesonide Maintenance Treatment Is Partially Effective for Patients With Eosinophilic Esophagitis  Alex Straumann, Sebastien Conus, Lukas Degen,
Anti–tumor necrosis factor monoclonal antibody therapy for gastrointestinal Behçet's disease: A case report  Philip V. Hassard, Scott W. Binder, Viera.
Long-Term Budesonide Maintenance Treatment Is Partially Effective for Patients With Eosinophilic Esophagitis  Alex Straumann, Sebastien Conus, Lukas Degen,
Volume 136, Issue 1, Pages (January 2009)
Volume 135, Issue 2, Pages e3 (August 2008)
Histological features of murine DSS-induced colitis.
Volume 132, Issue 4, Pages (April 2007)
Daniel K. Podolsky, Guido Gerken, Annette Eyking, Elke Cario 
Volume 119, Issue 1, Pages (July 2000)
B Cells That Produce Immunoglobulin E Mediate Colitis in BALB/c Mice
Diverticular Disease–Associated Segmental Colitis
Volume 138, Issue 4, Pages (April 2010)
Volume 136, Issue 7, Pages e4 (June 2009)
Volume 141, Issue 2, Pages e4 (August 2011)
Volume 134, Issue 4, Pages e2 (April 2008)
Redirection of Regulatory T Cells With Predetermined Specificity for the Treatment of Experimental Colitis in Mice  Eran Elinav, Tova Waks, Zelig Eshhar 
Volume 10, Issue 1, Pages (January 2015)
Targeting Improves MSC Treatment of Inflammatory Bowel Disease
Volume 15, Issue 2, Pages (February 2009)
Volume 144, Issue 5, Pages e6 (May 2013)
Volume 142, Issue 2, Pages e2 (February 2012)
Galectin-1 suppresses experimental colitis in mice
Volume 134, Issue 1, Pages e1 (January 2008)
The Triterpenoid CDDO-Me Delays Murine Acute Graft-versus-Host Disease with the Preservation of Graft-versus-Tumor Effects after Allogeneic Bone Marrow.
This month in Gastroenterology
Volume 136, Issue 3, Pages (March 2009)
Volume 136, Issue 2, Pages (February 2009)
Volume 134, Issue 4, Pages e2 (April 2008)
Volume 139, Issue 6, Pages (December 2010)
Volume 128, Issue 7, Pages (June 2005)
Volume 132, Issue 5, Pages (May 2007)
Volume 143, Issue 1, Pages (July 2012)
Volume 138, Issue 2, Pages (February 2010)
Volume 133, Issue 3, Pages (September 2007)
Volume 125, Issue 6, Pages (December 2003)
Volume 125, Issue 6, Pages (December 2003)
The Triterpenoid CDDO-Me Delays Murine Acute Graft-versus-Host Disease with the Preservation of Graft-versus-Tumor Effects after Allogeneic Bone Marrow.
Volume 134, Issue 7, Pages e3 (June 2008)
Therapeutic Action of Ghrelin in a Mouse Model of Colitis
Diagnosis of Colitis: Making the Initial Diagnosis
Volume 19, Issue 13, Pages (June 2017)
Volume 146, Issue 7, Pages e4 (June 2014)
Volume 129, Issue 1, Pages (July 2005)
Volume 135, Issue 2, Pages e2 (August 2008)
Heparin-Binding EGF-Like Growth Factor Increases Intestinal Microvascular Blood Flow in Necrotizing Enterocolitis  Xiaoyi Yu, Andrei Radulescu, Nicholas.
Blockade of poly(ADP-ribose) synthetase inhibits neutrophil recruitment, oxidant generation, and mucosal injury in murine colitis  Basilia Zingarelli,
Ling Zheng, Terrence E. Riehl, William F. Stenson  Gastroenterology 
Volume 132, Issue 3, Pages (March 2007)
Leptin: A pivotal mediator of intestinal inflammation in mice
Volume 139, Issue 4, Pages (October 2010)
Helminth Infection Enhances Disease in a Murine TH2 Model of Colitis
Colonic bacterial superantigens evoke an inflammatory response and exaggerate disease in mice recovering from colitis  Jun Lu, Arthur Wang, Sara Ansari,
Volume 131, Issue 2, Pages (August 2006)
Volume 125, Issue 3, Pages (September 2003)
Volume 136, Issue 7, Pages (June 2009)
Volume 132, Issue 3, Pages (March 2007)
Volume 127, Issue 3, Pages (September 2004)
Presentation transcript:

Volume 132, Issue 3, Pages 944-954 (March 2007) Nonmyeloablative Stem Cell Therapy Enhances Microcirculation and Tissue Regeneration in Murine Inflammatory Bowel Disease  Philipe N. Khalil, Véronique Weiler, Peter J. Nelson, Maurice N. Khalil, Sabine Moosmann, Wolf E. Mutschler, Matthias Siebeck, Ralf Huss  Gastroenterology  Volume 132, Issue 3, Pages 944-954 (March 2007) DOI: 10.1053/j.gastro.2006.12.029 Copyright © 2007 AGA Institute Terms and Conditions

Figure 1 Effect of adult CD34− stem cell therapy on the clinical activity in severe and moderate murine colitis. BALB/c mice received either 5% or 3% dextran sulfate sodium (DSS) with the drinking water in cyclic manner. Each cycle consisted of 7 days DSS followed by a 10-day period without DSS supplementation. Immortalized adult CD34− stem cells (SC) (2.0 × 106) were infused via the tail vein on days 8 and 25 without previous whole body ablation of the hosts. An additional 2 groups receiving no DSS but tap water throughout served as controls. Additionally, mice in one of the control groups received stem cells by tail vein injection as described. Mice receiving 3% (A) or 5% (B) DSS twice showed an increasing and decreasing clinical activity in contrast to controls (C) during the observation period of 35 days as obvious from the clinical activity score (CAS). The individual score, consisting of weight loss, stool consistency, and rectal bleeding is broken down separately at day 35 for the 3% and 5% DSS groups (D and E). Figures F and G show the Kaplan-Meier survival plots in mice fed with either 3% (F) or 5% (G) DSS. Thus, stem cell therapy reduced mortality by 50% and 60% in the 3% and 5% DSS feeding groups, respectively. Higher survival was statistically significant in severe colitis (P = .0001) but not in moderate colitis (P = .18). *P < .05, †P < .01, ‡P < .001, #P < .0001 for comparison between groups. Gastroenterology 2007 132, 944-954DOI: (10.1053/j.gastro.2006.12.029) Copyright © 2007 AGA Institute Terms and Conditions

Figure 2 Detection and differentiation of transfused adult CD34− stem cells in host mice. Representative colonic slices after therapeutic stem cell therapy without previous whole body ablation of the hosts in mice 35 days after induction of colitis with dextran sulfate sodium (DSS). Detection of GFP-marked CD 34− stem cells (A) and stem cells with SV40 large-T antigen expression (B and C) were detected in the subepithelial stroma layer and the close vicinity of newly formed blood vessels. The transfused cells also differentiated into endothelial cells of the growing vasculature by showing an activation of the Tie2-promotor, driving the red fluorescence protein (RFP) (E). Figure D shows a DAPI staining of the colon mucosa and submucosa; (F) overlay of pictures in C and E. Gastroenterology 2007 132, 944-954DOI: (10.1053/j.gastro.2006.12.029) Copyright © 2007 AGA Institute Terms and Conditions

Figure 3 Effect of adult CD34− stem cell therapy on morphologic alterations in severe and moderate murine colitis. BALB/c mice received either 5% or 3% dextran sulfate sodium (DSS) with the drinking water in a cyclic manner. Each cycle consisted of 7 days DSS followed by a 10-day period without DSS supplementation. Immortalized adult CD34− stem cells (SC) (2.0 × 106) were infused via the tail vein on days 8 and 25 without previous whole body ablation of the hosts. An additional 2 groups receiving no DSS but tap water throughout served as controls. Additionally, mice in one of the control groups received stem cells by tail vein injection as described. Mice fed with either 5% or 3% DSS and receiving stem cell therapy showed a significant lower macroscopic colonic damage score comprising grade of adhesions during removal of the entire colon, existence of ulcerations, and wall thickness compared with the corresponding controls (A). Stem cell therapy also reduced the shortening of the colon length (B) and increasing weight (C). A representative preparation of the entire alimentary system of a non-DSS-fed mouse is given in D, whereas E shows an excised colon of a mouse fed with 5% DSS and (F) a colon of a mouse fed with 5% DSS after stem cell therapy on days 8 and 25 after 35 days. The differences of colon length and wall thickness are obvious. Note the scale on the right side (D–F) and the different magnifications used. *P < .05, †P < .01, ‡P < .001, #P < .0001 for comparison between groups. NS, not significant. Gastroenterology 2007 132, 944-954DOI: (10.1053/j.gastro.2006.12.029) Copyright © 2007 AGA Institute Terms and Conditions

Figure 4 Histologic characteristics of adult CD34− stem cell therapy in murine colitis. Representative colonic slices after therapeutic stem cell therapy without previous whole body ablation of the hosts in mice 35 days after induction of colitis with dextran sulfate sodium (DSS). H&E-stained paraffin sections of murine colon mucosa and submucosa after 2 cycles of feeding 5% DSS with the drinking water and without CD34− stem cell therapy (A and B) show typical deep ulcerative damage; disordered mucosal architecture; diffuse depletion of goblet cells; and increased number of inflammatory cells (mononuclear cells and granulocytes) within the epithelium, the lamina propria, and the submucosa (original magnification in A, ×200; B, ×400). Mice that underwent stem cell therapy via the tail vein without previous whole body ablation for 5% DSS-induced colitis (C and D) showed only discrete epithelial lesion of the epithelium, focal depletion of goblet cells, and less inflammatory cells (mostly mononuclear cells) within the lamina propria and the submucosa (original magnification in C, ×200; D, ×400). Regular colon mucosa receiving neither DSS nor stem cell therapy is shown in E and F. The Figure shows no lesion of the epithelium, normal mucosal architecture, regular goblet cells, and an ordinary rate of inflammatory cells within the lamina propria. Gastroenterology 2007 132, 944-954DOI: (10.1053/j.gastro.2006.12.029) Copyright © 2007 AGA Institute Terms and Conditions

Figure 5 Effect of adult CD34− stem cell therapy on the histologic colonic severety in murine colitis. BALB/c mice received either 5% or 3% dextran sulfate sodium (DSS) with the drinking water in a cyclic manner. Each cycle consisted of 7 days followed by a 10-day period without DSS supplementation. Immortalized adult CD34− stem cells (SC) (2.0 × 106) were infused via the tail vein on days 8 and 25 without previous whole body ablation of the hosts. An additional 2 groups receiving no DSS but tap water throughout served as controls. Additionally, mice in one of the control groups received stem cells by tail vein injection as described. Mice fed with either 5% or 3% DSS and receiving stem cell therapy showed a significant lower histologic colonic severity score comprising the grade of inflammatory infiltration and tissue damage compared with controls (A). Stem cell therapy also reduced the number of affected colonic segments as detailed in B. *P < .05 for comparison between groups. NS, not significant. Gastroenterology 2007 132, 944-954DOI: (10.1053/j.gastro.2006.12.029) Copyright © 2007 AGA Institute Terms and Conditions